Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience ...

For superior performance in quality, delivery, innovation and partnership related to fluid dispensing systems used in ...

Skyrocketing technology requirements for AI data centers is expected to drive market demand for Photonic Integrated Circuits ...

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

ARGA Investment Management LP purchased a new position in Jabil Inc. (NYSE:JBL – Free Report) in the fourth quarter, ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...

With a plan to expand its pharmaceutical solutions arm, St. Pete-based engineering and manufacturing giant Jabil recently secured a deal to acquire Pharmaceutics International Inc.

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

In a regulatory filing, Jabil (JBL) director Christopher Holland disclosed the sale of 3,400 common shares of the company on January 31 at a ...